83 related articles for article (PubMed ID: 601218)
21. Basic principles of the immune response and the immunologic inhibition of tumors.
Vorlaender KO
Allergol Immunopathol (Madr); 1973 Jul; 1(4):235-46. PubMed ID: 4794103
[No Abstract] [Full Text] [Related]
22. Harnessing immunity for cancer marker discovery.
Hanash S
Nat Biotechnol; 2003 Jan; 21(1):37-8. PubMed ID: 12511908
[No Abstract] [Full Text] [Related]
23. [Antigenic markers in the cytological diagnosis of human malignant neoplasms].
Frank GA; Pugachev KK; Shabalova IP; Shimbireva IB
Arkh Patol; 1990; 52(8):70-4. PubMed ID: 2281989
[TBL] [Abstract][Full Text] [Related]
24. [Immunologic factors in the growth of malignant tumors].
Adolphs HD
Med Klin; 1976 Feb; 71(9):353-64. PubMed ID: 768731
[No Abstract] [Full Text] [Related]
25. Antibodies to a surface membrane marker from human mammary carcinoma cell line.
Kamiyama M; Hashim GA; Abdelaal A; Araujo L
Cancer Res; 1987 May; 47(9):2433-9. PubMed ID: 3567928
[TBL] [Abstract][Full Text] [Related]
26. Novel antibodies as anticancer agents.
Zafir-Lavie I; Michaeli Y; Reiter Y
Oncogene; 2007 May; 26(25):3714-33. PubMed ID: 17530025
[TBL] [Abstract][Full Text] [Related]
27. Circulating immune complexes in malignant melanoma.
Gupta RK
Dis Markers; 1988 Jun; 6(2):81-95. PubMed ID: 3042263
[No Abstract] [Full Text] [Related]
28. Editorial: Carcinoembryonic antigen.
Hickok DF
Minn Med; 1973 Nov; 56(11):970. PubMed ID: 4756989
[No Abstract] [Full Text] [Related]
29. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
Lu H; Goodell V; Disis ML
J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
[TBL] [Abstract][Full Text] [Related]
30. Quantification of circulating immune complexes in cancer of the gastrointestinal tract.
Sanz ML; Oehling A; Lera JM; Hernández JL; Fernández J
Allergol Immunopathol (Madr); 1982; 10(5):373-80. PubMed ID: 7164993
[No Abstract] [Full Text] [Related]
31. Immunological prostate cancer test developed.
J Med Assoc State Ala; 1973 Oct; 43(4):278. PubMed ID: 4583455
[No Abstract] [Full Text] [Related]
32. The role of circulating antigen as an inhibitor of tumour immunity in man.
Currie G
Br J Cancer Suppl; 1973 Aug; 1():153-61. PubMed ID: 4804278
[No Abstract] [Full Text] [Related]
33. [Immunohistochemical and radiologic study of the accumulation of antibodies to the beta-1-MA antigen in human tumors transplanted into athymic mice].
Pugachev KK; Aleksandr SK; Fidler LM; Revazova ES; Shimbireva IB
Eksp Onkol; 1989; 11(1):50-3. PubMed ID: 2466632
[TBL] [Abstract][Full Text] [Related]
34. [Cell receptors and tumor markers].
Verh Dtsch Ges Pathol; 1986; 70():1-691. PubMed ID: 3030017
[No Abstract] [Full Text] [Related]
35. A simple test for detection of specific and unspecific immunological reactions in cancer.
Ruíz Castañeda M
Arch Invest Med (Mex); 1980; 11(1):83-93. PubMed ID: 7396635
[TBL] [Abstract][Full Text] [Related]
36. The immune system in gynecologic malignancies.
Barber HR; Dorsett BH
Mt Sinai J Med; 1980; 47(5):539-49. PubMed ID: 6969360
[No Abstract] [Full Text] [Related]
37. What's new in surgery. Tumors.
Fisher B
Surg Gynecol Obstet; 1973 Feb; 136(2):216-9. PubMed ID: 4631364
[No Abstract] [Full Text] [Related]
38. Monoclonal antibody characterization of a tumor-associated breast cancer antigen.
Edwards DP; Dressler LG; Zava DT; McGuire WL
Prog Clin Biol Res; 1986; 204():71-88. PubMed ID: 2421350
[No Abstract] [Full Text] [Related]
39. Tumor-specific immunity.
Smith RT
Adv Pathobiol; 1976; 4():74-85. PubMed ID: 1023768
[No Abstract] [Full Text] [Related]
40. Identification of tumour antigens by serological analysis of cDNA expression cloning.
Li G; Miles A; Line A; Rees RC
Cancer Immunol Immunother; 2004 Mar; 53(3):139-43. PubMed ID: 14722670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
